 - History of, or abnormal laboratory results indicative of, any significant cardiac, endocrinologic, hematologic, hepatic, immunologic, metabolic, urologic, pulmonary, gastrointestinal, dermatologic, psychiatric, renal, andor other major disease that, in the opinion of the investigator, would preclude the administration of natalizumab for the duration of the study. 